FDA Import Refusal AEK-1803079-9/11/1 — Lilly France S.A.S.
The FDA refused shipment AEK-1803079-9/11/1 from Lilly France S.A.S. (France) on Oct 3, 2022. The refused product falls under Drugs and Biologics — INSULIN BIOSYNTHETIC HUMAN (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Oct 3, 2022
- Country
- France
- Product Category
- Drugs and Biologics
- Product Code
- 61PCP33 INSULIN BIOSYNTHETIC HUMAN (ANTI-DIABETIC)
- Charges
- 75